346 related articles for article (PubMed ID: 24755997)
1. Current and emerging therapies for Addison's disease.
Napier C; Pearce SH
Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):147-53. PubMed ID: 24755997
[TBL] [Abstract][Full Text] [Related]
2. Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy.
Björnsdottir S; Øksnes M; Isaksson M; Methlie P; Nilsen RM; Hustad S; Kämpe O; Hulting AL; Husebye ES; Løvås K; Nyström T; Bensing S
Clin Endocrinol (Oxf); 2015 Jul; 83(1):28-35. PubMed ID: 25400085
[TBL] [Abstract][Full Text] [Related]
3. Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison's disease: a randomized clinical trial.
Oksnes M; Björnsdottir S; Isaksson M; Methlie P; Carlsen S; Nilsen RM; Broman JE; Triebner K; Kämpe O; Hulting AL; Bensing S; Husebye ES; Løvås K
J Clin Endocrinol Metab; 2014 May; 99(5):1665-74. PubMed ID: 24517155
[TBL] [Abstract][Full Text] [Related]
4. Addison's disease in pregnancy: Case report, management, and review of the literature.
Margulies SL; Corrigan K; Bathgate S; Macri C
J Neonatal Perinatal Med; 2020; 13(2):275-278. PubMed ID: 31744021
[TBL] [Abstract][Full Text] [Related]
5. Addison's Disease and Pituitary Enlargement.
Winters SJ; Vitaz T; Nowacki MR; Craddock DC; Silverman C
Am J Med Sci; 2015 Jun; 349(6):526-9. PubMed ID: 25004119
[TBL] [Abstract][Full Text] [Related]
6. Replacement therapy for Addison's disease: recent developments.
Løvås K; Husebye ES
Expert Opin Investig Drugs; 2008 Apr; 17(4):497-509. PubMed ID: 18363515
[TBL] [Abstract][Full Text] [Related]
7. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
Fichna M; Gryczyńska M; Sowińska A; Sowiński J
Przegl Lek; 2011; 68(2):96-102. PubMed ID: 21751518
[TBL] [Abstract][Full Text] [Related]
8. Continuous subcutaneous hydrocortisone infusion therapy in Addison's disease: a randomized, placebo-controlled clinical trial.
Gagliardi L; Nenke MA; Thynne TR; von der Borch J; Rankin WA; Henley DE; Sorbello J; Inder WJ; Torpy DJ
J Clin Endocrinol Metab; 2014 Nov; 99(11):4149-57. PubMed ID: 25127090
[TBL] [Abstract][Full Text] [Related]
9. [Addison's disease : Primary adrenal insufficiency].
Pulzer A; Burger-Stritt S; Hahner S
Internist (Berl); 2016 May; 57(5):457-69. PubMed ID: 27129928
[TBL] [Abstract][Full Text] [Related]
10. Secondary pituitary hyperplasia in Addison's disease.
Clayton R; Burden AC; Schrieber V; Rosenthal FD
Lancet; 1977 Nov; 2(8045):954-6. PubMed ID: 72291
[TBL] [Abstract][Full Text] [Related]
11. Addison's disease.
Nieman LK; Chanco Turner ML
Clin Dermatol; 2006; 24(4):276-80. PubMed ID: 16828409
[TBL] [Abstract][Full Text] [Related]
12. Takotsubo-like syndrome triggered by fludrocortisone overdose for Addison's disease: a case report.
Campean R; Hasun M; Stöllberger C; Bucher J; Finsterer J; Schnack C; Weidinger F
J Med Case Rep; 2016 Oct; 10(1):281. PubMed ID: 27729057
[TBL] [Abstract][Full Text] [Related]
13. Recurrent nocturnal hypoglycaemia as a cause of morning fatigue in treated Addison's disease--favourable response to dietary management: a case report.
Petersen KS; Rushworth RL; Clifton PM; Torpy DJ
BMC Endocr Disord; 2015 Oct; 15():61. PubMed ID: 26500000
[TBL] [Abstract][Full Text] [Related]
14. What steroid supplementation is required for a patient with primary adrenal insufficiency undergoing a dental procedure?
Henderson S
Dent Update; 2014 May; 41(4):342-4. PubMed ID: 24930256
[TBL] [Abstract][Full Text] [Related]
15. Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison's disease.
Giordano R; Guaraldi F; Marinazzo E; Fumarola F; Rampino A; Berardelli R; Karamouzis I; Lucchiari M; Manetta T; Mengozzi G; Arvat E; Ghigo E
Endocrine; 2016 Feb; 51(2):360-8. PubMed ID: 26184416
[TBL] [Abstract][Full Text] [Related]
16. [Therapy of Addison's disease].
Tiede N; Hofbauer LC; Bornstein SR; Kirch W
Dtsch Med Wochenschr; 2010 Aug; 135(31-32):1561-2. PubMed ID: 20665422
[No Abstract] [Full Text] [Related]
17. [Addison's disease].
Quinkler M
Med Klin Intensivmed Notfmed; 2012 Sep; 107(6):454-9. PubMed ID: 22907517
[TBL] [Abstract][Full Text] [Related]
18. Addison's disease as a primary manifestation of extrapulmonary tuberculosis; A case report.
Ranawaka N; Welikumbura NH
Indian J Tuberc; 2021 Jul; 68(3):405-407. PubMed ID: 34099210
[TBL] [Abstract][Full Text] [Related]
19. Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison's disease on glucocorticoid and mineralocorticoid replacement therapy.
Camozzi V; Betterle C; Frigo AC; Zaccariotto V; Zaninotto M; De Caneva E; Lucato P; Gomiero W; Garelli S; Sabbadin C; Salvà M; Costa MD; Boscaro M; Luisetto G
Endocrine; 2018 Feb; 59(2):319-329. PubMed ID: 28795340
[TBL] [Abstract][Full Text] [Related]
20. [Cardiovascular and metabolic impact of glucocorticoid substitution therapy in patients with Addison's disease].
Salah DB; Charfi N; Elleuch M; Kacem FH; Rekik N; Mnif M; Mnif F; Abid M
Pan Afr Med J; 2018; 30():251. PubMed ID: 30627312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
